# What flavors will JUUL relaunch?

In 2027

Updated: June 5, 2026

Category: Financials

Tags: Product launches
Companies

HTML: /markets/financials/product-launches/what-flavors-will-juul-relaunch/

## Short Answer

**Key takeaway.** The **model** forecasts Mint as the most likely flavor for JUUL to relaunch in 2027, but assigns significantly lower odds (**11.8%** **model** vs **30.0%** **market**) compared to the **market**.

## Key Claims (January 2026)

**- - FDA authorization for JUUL2 flavored pods appears essential before 2027.** - JUUL filings offer no specific evidence for a Mint flavor relaunch.
- JUUL's financial stability concerns may hinder costly FDA applications.
- Only Virginia Tobacco and Menthol flavors were FDA authorized as of June 2026.
- A change in FDA flavor authorization appears the primary U.S. catalyst.

### Why This Matters (GEO)

- AI agents extract claims, not arguments.
- Improves citation probability in summaries and answer cards.
- Enables fact stitching across multiple sources.

## Executive Verdict

**Key takeaway.** **Market**'s **9.0%** **probability**, 6.6pp above the **2.4%** **model**, lacks FDA authorization evidence for flavor relaunch.

### Who Wins and Why

| Outcome | Market | Model | Why |
| --- | --- | --- | --- |
| Mango | 9.0% | 2.4% | Mango may be relaunched by JUUL. |
| Mint | 30.0% | 11.8% | Mint may be relaunched by JUUL. |
| Cool Mint | 15.0% | 6.9% | Cool Mint may be relaunched by JUUL. |

## Model vs Market

| Outcome | Market Probability | Octagon Model Probability |
| --- | --- | --- |
| Mango | 9.0% | 2.4% |
| Mint | 30.0% | 11.8% |
| Cool Mint | 15.0% | 6.9% |
| Cucumber | 21.0% | 10.8% |
| Crème Brûlée | 14.0% | 6.3% |
| Fruit Medley | 14.0% | 6.3% |

- Expiration: January 1, 2027

## Market Behavior & Price Dynamics

This prediction market, which tracks the probability of JUUL relaunching its Mango flavor by 2027, has been characterized by a sideways trend and significant volatility in response to regulatory news. The price has fluctuated within a range of 2.0% to 17.0%, starting at 8.0% and currently trading at 9.0%. A period of intense activity occurred at the end of May 2026, beginning with a drop from 10.0% to 2.0% as the market processed that an FDA authorization for fruit-flavored e-cigarettes was for companies other than JUUL. This was immediately followed by a sharp spike to a high of 16.0% on May 31, driven by renewed speculation that the FDA's approval of any fruit flavor was a positive signal for the entire category. However, this optimism was short-lived, as the price fell back to 9.0% on June 5 in what appears to be a market correction, factoring in the continued lack of any specific news or authorization for JUUL's fruit products.

The price action indicates key technical levels and reflects a speculative market sentiment. Resistance was established around the 16.0%-17.0% level, which capped the late-May rally, while support was found at 2.0% during the initial dip. The current price of 9.0% is hovering near the market's opening price, suggesting a return to a baseline sentiment of skepticism after a period of high volatility. The total volume of 1,250 contracts traded suggests moderate engagement. Overall, the chart indicates that traders see the relaunch of Mango as a low-probability event, but sentiment remains highly sensitive to any broader regulatory developments in the e-cigarette industry, even those not directly involving JUUL.

## Significant Price Movements

### Outcome: Mango

#### 📉 June 05, 2026: 8.0pp drop

Price decreased from 17.0% to 9.0%

**What happened:** The 8.0 percentage point drop in the "Mango" outcome for JUUL's potential relaunch on June 05, 2026, appears to be a market correction stemming from the continued absence of any official announcement or specific FDA authorization for JUUL's fruit-flavored products in the U.S. [[^]](https://fortune.com/2026/05/07/fda-authorizes-fruit-flavored-vapes-mango-blueberry-trump-administration-american-politics-tobacco-companies/). While the FDA authorized fruit-flavored vapes for another manufacturer in May 2026, initially sparking broader speculative interest for the category [[^]](https://polymarket.com/event/which-flavors-will-juul-relaunch-in-2026)[[^]](https://dailyprogress.com/news/nation-world/government-politics/article_fb95e409-d29e-517b-8b37-e2cf84468bfe.html)[[^]](https://www.pharmacytimes.com/view/fda-authorizes-first-ever-fruit-flavored-ends-products-marking-major-policy-shift), this optimism for JUUL specifically lacked a direct catalyst by June 05, 2026 [[^]](https://fortune.com/2026/05/07/fda-authorizes-fruit-flavored-vapes-mango-blueberry-trump-administration-american-politics-tobacco-companies/). No specific social media activity on X or other platforms from key figures, nor new traditional news from major outlets, was identified on or around June 05, 2026, that directly caused this movement. Consequently, social media was irrelevant in causing this market shift.

#### 📈 May 31, 2026: 14.0pp spike

Price increased from 2.0% to 16.0%

**What happened:** The primary driver of the 14.0 percentage point spike in the "Mango" outcome was the FDA's authorization of non-tobacco/non-menthol fruit-flavored vapes, including mango, for other companies in May 2026 [[^]](https://dailyprogress.com/news/nation-world/government-politics/article_fb95e409-d29e-517b-8b37-e2cf84468bfe.html). This regulatory shift, which reportedly followed political pressure to authorize such flavors, signaled a potential softening in the overall stance towards fruit-flavored vape products [[^]](https://dailyprogress.com/news/nation-world/government-politics/article_fb95e409-d29e-517b-8b37-e2cf84468bfe.html). Although this specific authorization did not include JUUL products [[^]](https://dailyprogress.com/news/nation-world/government-politics/article_fb95e409-d29e-517b-8b37-e2cf84468bfe.html), it likely increased optimism among prediction market participants regarding the eventual reintroduction of JUUL's "Mango" flavor. Social media activity was irrelevant as no related posts from key figures or viral narratives were identified in the available research.

#### 📉 May 30, 2026: 8.0pp drop

Price decreased from 10.0% to 2.0%

**What happened:** The 8.0 percentage point drop in the "Mango" prediction market on May 30, 2026, was primarily driven by the market's re-evaluation of a traditional news announcement [[^]](https://polymarket.com/event/which-flavors-will-juul-relaunch-in-2026). Earlier in May 2026, the FDA granted its first marketing authorization for fruit-flavored e-cigarettes (Mango and Blueberry) to competitor Glas, Inc., which initially sparked speculation about JUUL's future portfolio, leading to an early May market peak [[^]](https://polymarket.com/event/which-flavors-will-juul-relaunch-in-2026)[[^]](https://fortune.com/2026/05/07/fda-authorizes-fruit-flavored-vapes-mango-blueberry-trump-administration-american-politics-tobacco-companies/)[[^]](https://ecigintelligence.com/us-fda-fruit-vape-nod-signals-regulatory-shift-more-than-instant-market-impact/)[[^]](https://www.newser.com/article/ff2701ce00d797194666917beca43de6/fda-announces-its-first-ok-of-fruit-flavored-e-cigarettes-for-adults-in-major-shift-under-trump.html). However, the subsequent price decline reflected a clearer understanding that this specific FDA approval did not apply to JUUL Labs [[^]](https://fortune.com/2026/05/07/fda-authorizes-fruit-flavored-vapes-mango-blueberry-trump-administration-american-politics-tobacco-companies/)[[^]](https://ecigintelligence.com/us-fda-fruit-vape-nod-signals-regulatory-shift-more-than-instant-market-impact/). Social media activity was not explicitly identified as a primary driver for this particular price drop.

### Outcome: Cucumber

#### 📈 May 22, 2026: 11.0pp spike

Price increased from 9.0% to 20.0%

**What happened:** The provided sources do not contain information identifying the cause of the 11.0 percentage point price spike for "Cucumber" flavor on May 22, 2026. While the U.S. FDA has authorized Virginia Tobacco and Menthol flavors for sale [[^]](https://thehill.com/policy/healthcare/5406647-fda-reverses-ban-juul-e-cigarettes/), and Juul Labs UK expanded its JUUL2 flavor portfolio with other variants like Mango and Watermelon in January 2026 [[^]](https://nicotineinsider.com/2026/01/04/juul-labs-uk-expands-juul2-flavor-portfolio/), none of these reports mention cucumber or any specific event correlating with the May 22, 2026, market movement. Therefore, social media cannot be identified as a primary driver or contributing accelerant based on the available data.

## Contract Snapshot

The Mint market resolves to Yes if JUUL releases Mint, Cool Mint, or any other mint-related flavor to the public before January 1, 2027. If none of these events occur, the market resolves to No and closes by December 31, 2026, 11:59pm EST. Outcomes are verified from Juul.com.

## Market Discussion

The market discussion revolves around whether JUUL will relaunch popular flavors like Mint, Cool Mint, and potentially fruit flavors such as Mango. Traders supporting a relaunch point to recent FDA approvals for fruit-flavored vapes from other brands as a potential precedent for JUUL, and some believe FDA approval of menthol flavors paves the way for mint. However, a significant counter-argument emphasizes that menthol is distinct from mint, and mint might still be considered a disallowed flavor by the FDA.

## Market Data

| Contract | Yes Bid | Yes Ask | Last Price | Volume | Open Interest |
| --- | --- | --- | --- | --- | --- |
| Cool Mint | 14% | 19% | 15% | $5,050.29 | $2,071.38 |
| Crème Brûlée | 6% | 14% | 14% | $805.64 | $547.54 |
| Cucumber | 22% | 27% | 21% | $4,176.32 | $2,729.12 |
| Fruit Medley | 6% | 14% | 14% | $396.05 | $350.04 |
| Mango | 9% | 17% | 9% | $24,719.77 | $7,929.22 |
| Mint | 25% | 30% | 30% | $16,689.15 | $7,117.64 |

## What key milestones in the FDA's review of the JUUL2 device could serve as catalysts for a flavor relaunch before 2027?

JUUL2 PMTA Submission | July 2023 [[^]](https://www.juullabs.com/wp-content/uploads/2023/10/Letter-from-Joe-Murillo-to-Dr.-Brian-King-Regarding-Referral-of-JLIs-PMTAs-to-TPSAC.pdf)[[^]](https://tobaccoreporter.com/2023/07/20/juul-seeks-fda-authorization-for-juul2-system/) |
JUUL2 Menthol Pod PMTA Status | Submitted [[^]](https://vaping360.com/vape-news/127944/juul-submits-pmta-for-next-generation-menthol-pod/) |
Original JUUL Menthol Pod Authorization | July 17, 2025 [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-tobacco-and-menthol-flavored-juul-e-cigarette-products) |

**FDA authorization for JUUL2 and its flavored pods is essential**

FDA authorization for JUUL2 and its flavored pods is essential. For a flavor relaunch concerning the JUUL2 device to occur before 2027, the FDA must grant marketing authorization for both the JUUL2 system and its specific flavored pods. JUUL submitted Premarket Tobacco Product Applications (PMTAs) for the JUUL2 system in July 2023 [[^]](https://www.juullabs.com/wp-content/uploads/2023/10/Letter-from-Joe-Murillo-to-Dr.-Brian-King-Regarding-Referral-of-JLIs-PMTAs-to-TPSAC.pdf)[[^]](https://tobaccoreporter.com/2023/07/20/juul-seeks-fda-authorization-for-juul2-system/). Additionally, JUUL has submitted a PMTA for a menthol next-generation platform pod designed exclusively for the JUUL2 device [[^]](https://vaping360.com/vape-news/127944/juul-submits-pmta-for-next-generation-menthol-pod/).

The FDA has not yet authorized JUUL2 or its flavors. While the FDA authorized the marketing of Menthol-flavored JUUL pods (**3%** and **5%** nicotine) on July 17, 2025, alongside Virginia Tobacco-flavored pods, this authorization was specifically for the original JUUL device [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-tobacco-and-menthol-flavored-juul-e-cigarette-products). The FDA's review process for JUUL products previously included marketing denial orders issued on June 23, 2022. However, these orders were rescinded on June 6, 2024, effectively returning the PMTAs to a 'pending status' under substantive review [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/update-fdas-scientific-review-juul-product-applications)[[^]](https://www.accessdata.fda.gov/static/searchtobacco/7-10-25/Juul-TPL-Rev-Multiple-STNs.pdf). Crucially, the available research indicates that the FDA has not authorized the marketing of the JUUL2 device or any flavored pods exclusively for the JUUL2 system.

## What specific evidence in JUUL's regulatory filings supports the market consensus favoring a Mint or Cool Mint relaunch over other banned flavors?

FDA Authorized Flavors | Menthol and Virginia Tobacco (3% and 5% nicotine) [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-tobacco-and-menthol-flavored-juul-e-cigarette-products) |
Total Authorized JUUL Products | 5 (JUUL device, Virginia Tobacco 3% and 5% pods, Menthol 3% and 5% pods) [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-tobacco-and-menthol-flavored-juul-e-cigarette-products) |
Mint/Cool Mint Status | Not currently authorized; would require separate FDA marketing authorization [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-tobacco-and-menthol-flavored-juul-e-cigarette-products)[[^]](https://www.accessdata.fda.gov/static/searchtobacco/7-10-25/Juul-TPL-Rev-Multiple-STNs.pdf)[[^]](https://www.fda.gov/media/179499/download) |

**JUUL's regulatory filings offer no specific evidence for a Mint or Cool Mint relaunch**

JUUL's regulatory filings offer no specific evidence for a Mint or Cool Mint relaunch. The available public records from the U.S. Food and Drug Administration (FDA) explicitly support menthol as an authorized flavor for JUUL products, not mint or Cool Mint [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-tobacco-and-menthol-flavored-juul-e-cigarette-products). The FDA’s authorization on July 17, 2025, specifically approved the marketing of five JUUL e-cigarette products: the JUUL device, Virginia Tobacco pods (**3%** and **5%** nicotine), and Menthol pods (**3%** and **5%** nicotine) [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-tobacco-and-menthol-flavored-juul-e-cigarette-products).

The FDA's technical review process did not recommend Mint or Cool Mint. The FDA’s Technical Project Lead (TPL) review for JUUL's Premarket Tobacco Product Applications (PMTAs) analyzed and specifically recommended marketing orders for JUULpods Menthol **3.0%**, Menthol **5.0%**, Virginia Tobacco **3.0%**, Virginia Tobacco **5.0%**, and the JUUL Device [[^]](https://www.accessdata.fda.gov/static/searchtobacco/7-10-25/Juul-TPL-Rev-Multiple-STNs.pdf)[[^]](https://www.fda.gov/media/179499/download). There was no corresponding recommendation for mint or Cool Mint products. Consequently, any **market** consensus suggesting a relaunch of "Mint" or "Cool Mint" is not supported by these specific FDA regulatory filings regarding granted or authorized flavors. Such a relaunch would be speculative and necessitate separate FDA marketing authorization via the PMTA pathway [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-tobacco-and-menthol-flavored-juul-e-cigarette-products)[[^]](https://www.accessdata.fda.gov/static/searchtobacco/7-10-25/Juul-TPL-Rev-Multiple-STNs.pdf)[[^]](https://www.fda.gov/media/179499/download).

## How does the FDA's regulatory framework for flavored e-cigarettes compare to the UK's, and what does this imply for Mango's U.S. relaunch prospects?

US Flavor Regulation | Restrictive premarket authorization for non-tobacco flavors [[^]](https://www.fdli.org/2025/05/what-happens-in-the-real-world-when-flavors-are-banned-in-nicotine-products/)[[^]](https://fda.gov/media/191455/download)[[^]](https://www.ecigclick.co.uk/vape-regulation-two-directions-usa-uk/)[[^]](https://www.reynoldsamerican.com/wp-content/uploads/2026/05/ReynoldsAmericanComment_FDADraft-Guidance-re_Flavored-ENDS_MAR2026.pdf) |
UK Flavor Regulation Trend | Moving towards stricter oversight, with potential future flavor and display restrictions [[^]](https://www.fdli.org/2025/05/what-happens-in-the-real-world-when-flavors-are-banned-in-nicotine-products/)[[^]](https://www.ecigclick.co.uk/vape-regulation-two-directions-usa-uk/)[[^]](https://www.reynoldsamerican.com/wp-content/uploads/2026/05/ReynoldsAmericanComment_FDADraft-Guidance-re_Flavored-ENDS_MAR2026.pdf) |
Mango U.S. Relaunch Status | Faces substantial hurdles, no official FDA authorization as of June 2026 [[^]](https://polymarket.com/event/which-flavors-will-juul-relaunch-in-2026) |

**The FDA imposes strict premarket authorization for flavored e-cigarettes**

The FDA imposes strict premarket authorization for flavored e-cigarettes. The U.S. Food and Drug Administration (FDA) employs a restrictive premarket authorization (PMTA) framework for non-tobacco flavored e-cigarettes. Manufacturers are required to demonstrate that such products provide an 'added benefit' to adult smokers when compared to tobacco-flavored options, while simultaneously minimizing risks to youth [[^]](https://www.fdli.org/2025/05/what-happens-in-the-real-world-when-flavors-are-banned-in-nicotine-products/)[[^]](https://fda.gov/media/191455/download)[[^]](https://www.ecigclick.co.uk/vape-regulation-two-directions-usa-uk/)[[^]](https://www.reynoldsamerican.com/wp-content/uploads/2026/05/ReynoldsAmericanComment_FDADraft-Guidance-re_Flavored-ENDS_MAR2026.pdf). This stringent evidentiary burden creates significant challenges for any flavored e-cigarette seeking to relaunch in the U.S. **market**.

UK regulations are tightening, but flavored U.S. relaunch faces hurdles. In contrast to the U.S., the UK historically utilized a more permissive, notification-based system for e-cigarettes. However, the UK is now moving towards stricter regulation with the Tobacco and Vapes Act (2026), which may introduce future restrictions on flavors and product displays [[^]](https://www.fdli.org/2025/05/what-happens-in-the-real-world-when-flavors-are-banned-in-nicotine-products/)[[^]](https://www.ecigclick.co.uk/vape-regulation-two-directions-usa-uk/)[[^]](https://www.reynoldsamerican.com/wp-content/uploads/2026/05/ReynoldsAmericanComment_FDADraft-Guidance-re_Flavored-ENDS_MAR2026.pdf). Given the FDA's high evidentiary standards, the prospects for a flavored U.S. relaunch, such as Mango, confront substantial obstacles [[^]](https://fda.gov/media/191455/download)[[^]](https://www.ecigclick.co.uk/vape-regulation-two-directions-usa-uk/)[[^]](https://www.reynoldsamerican.com/wp-content/uploads/2026/05/ReynoldsAmericanComment_FDADraft-Guidance-re_Flavored-ENDS_MAR2026.pdf). While prediction markets have identified Mango as a potential target, there have been no official company announcements or FDA authorizations for these specific flavors as of June 2026 [[^]](https://polymarket.com/event/which-flavors-will-juul-relaunch-in-2026).

## What public dockets and FDA databases can be used to track the progress of JUUL's pending Premarket Tobacco Product Applications (PMTAs)?

Initial MDOs Issued | June 23, 2022 [[^]](https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/tobacco-products-marketing-orders) |
MDOs Administratively Stayed | July 5, 2022 [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/update-fdas-scientific-review-juul-product-applications) |
MDOs Rescinded, Applications Pending | June 6, 2024 [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/update-fdas-scientific-review-juul-product-applications) |

**FDA offers specific databases and pages to track JUUL’s PMTA progress**

FDA offers specific databases and pages to track JUUL’s PMTA progress. Key FDA resources for monitoring JUUL's pending Premarket Tobacco Product Applications (PMTAs) include the "Tobacco Products Marketing Orders" page for major decisions [[^]](https://www.fda.gov/tobacco-products/**market**-and-distribute-tobacco-product/tobacco-products-marketing-orders) and the "Update on FDA’s Scientific Review of JUUL Product Applications" page, which provides specific procedural updates regarding JUUL [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/update-fdas-scientific-review-juul-product-applications). For broader application metrics and progress tracking, the "Tobacco Product Applications: Metrics & Reporting" page presents regularly updated metrics across various review phases, such as Acceptance, Filing, and Review/Action, and links to a searchable database [[^]](https://www.fda.gov/tobacco-products/**market**-and-distribute-tobacco-product/tobacco-product-applications-metrics-reporting). Furthermore, underlying technical documentation and JUUL-related PMTA technical review and record documents, including PDFs detailing FDA review milestones, are accessible through FDA-hosted AccessData "searchtobacco" static documents [[^]](https://www.accessdata.fda.gov/static/searchtobacco/7-10-25/Juul-TPL-Rev-Multiple-STNs.pdf).

JUUL's PMTA status evolved through MDOs, stays, and rescission. The FDA initially issued marketing denial orders (MDOs) for JUUL Labs Inc. on June 23, 2022 [[^]](https://www.fda.gov/tobacco-products/**market**-and-distribute-tobacco-product/tobacco-products-marketing-orders). These MDOs were subsequently subjected to an administrative stay on July 5, 2022, and were officially rescinded on June 6, 2024 [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/update-fdas-scientific-review-juul-product-applications). Following the rescission, JUUL's applications were returned to a pending status, indicating they are once again undergoing substantive review by the FDA [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/update-fdas-scientific-review-juul-product-applications).

## How does JUUL Labs' current financial health impact its ability to fund the costly FDA application process for multiple flavors before 2027?

Authorized Flavors (US) | Tobacco and menthol (as of June 2026) [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-tobacco-and-menthol-flavored-juul-e-cigarette-products) |
Former Company Valuation | $38 billion [[^]](https://pitchbook.com/profiles/company/223456-87)[[^]](https://www.youtube.com/watch?v=Mv01IhCjLsI)[[^]](https://www.ft.com/stream/9c0bfa8f-4b92-4a93-aa47-f3affda81298)[[^]](https://nationalrecordretrieval.com/blog/juul-labs-avoids-bankruptcy-and-settles-thousands-of-vaping-lawsuits-with-new-equity-investment/) |
FDA Guidance for Non-Tobacco/Menthol Flavors | March 2026 (draft guidance issued) [[^]](https://www.tobaccolawblog.com/2026/03/fda-issues-draft-guidance-on-flavored-ends-pmtas/)[[^]](https://news.bloomberglaw.com/health-law-and-business/e-cigarette-makers-object-to-how-fda-will-review-flavored-vapes) |

**JUUL's financial stability is a significant concern for funding FDA applications**

JUUL's financial stability is a significant concern for funding FDA applications. The company's capacity to finance the expensive FDA application process required for various non-tobacco and non-menthol flavors before 2027 is directly impacted by its current financial state. Extensive restructuring measures, including substantial workforce reductions and multi-billion dollar settlements, were undertaken to prevent bankruptcy. Consequently, JUUL has become a diminished entity compared to its previous **$38** billion valuation [[^]](https://pitchbook.com/profiles/company/223456-87)[[^]](https://www.youtube.com/watch?v=Mv01IhCjLsI)[[^]](https://www.ft.com/stream/9c0bfa8f-4b92-4a93-aa47-f3affda81298)[[^]](https://nationalrecordretrieval.com/blog/juul-labs-avoids-bankruptcy-and-settles-thousands-of-vaping-lawsuits-with-new-equity-investment/).

FDA regulations complicate JUUL's future flavor authorization efforts. As of June 2026, JUUL Labs is only authorized to sell tobacco and menthol flavored products in the United States, with no official timeline for reintroducing other flavors [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-tobacco-and-menthol-flavored-juul-e-cigarette-products). The FDA's draft guidance, issued in March 2026, establishes a rigorous and costly pathway for Premarket Tobacco Product Applications (PMTAs) for non-tobacco and non-menthol flavors [[^]](https://www.tobaccolawblog.com/2026/03/fda-issues-draft-guidance-on-flavored-ends-pmtas/)[[^]](https://news.bloomberglaw.com/health-law-and-business/e-cigarette-makers-object-to-how-fda-will-review-flavored-vapes). This guidance significantly increases the expense and complexity of obtaining future flavor authorizations for companies like JUUL, as each potential flavor relaunch requires a separate, expensive FDA marketing authorization, further straining JUUL's financial resources [[^]](https://kalshi.com/markets/kxjuulflavor/juul-flavors/kxjuulflavor-27).

## What Could Change the Odds

**The primary catalyst for JUUL in the U.S.** **market** would be a change in FDA authorization regarding e-cigarette product flavors. As of June 5, 2026, the only JUUL e-cigarette products authorized by the U.S. FDA for marketing are the JUUL device, Virginia Tobacco-flavored JUULpods (**3%** and **5%** nicotine), and Menthol-flavored JUULpods (**3%** and **5%** nicotine) [[^]](https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-tobacco-and-menthol-flavored-juul-e-cigarette-products)[[^]](https://www.smokeaxis.com/compliance/pmta). Prediction markets for a U.S. JUUL flavor relaunch in 2026 indicate bearish sentiment, with low probabilities assigned to the reintroduction of flavors such as Mango or Mint, largely due to persistent regulatory hurdles and the lack of FDA authorization for any flavors other than tobacco and menthol [[^]](https://polymarket.com/event/which-flavors-will-juul-relaunch-in-2026). JUUL Labs has been actively expanding its flavor portfolio in international markets, such as the UK, where it introduced JUUL2 Peach pods in January 2026, following the launch of several single-fruit flavors in late 2025; however, these do not impact U.S. availability [[^]](https://nicotineinsider.com/2026/01/04/juul-labs-uk-expands-juul2-flavor-portfolio/)[[^]](https://www.juullabs.co.uk/juul-labs-launches-next-generation-juul2-system-across-uk-retail-stores/).

**Another significant catalyst involves JUUL's financial and legal challenges.** The company faces considerable financial pressure in 2026 due to ongoing multi-state settlement obligations exceeding **$1.7** billion [[^]](https://investor.altria.com/press-releases/news-details/2026/Altria-Reports-2026-First-Quarter-Results-Reaffirms-Full-Year-Guidance/default.aspx). Additionally, active litigation, including an antitrust trial scheduled for September 2026, presents further potential impacts on the company's **market** position [[^]](https://investor.altria.com/press-releases/news-details/2026/Altria-Reports-2026-First-Quarter-Results-Reaffirms-Full-Year-Guidance/default.aspx)[[^]](https://www.sec.gov/Archives/edgar/data/764180/000076418026000056/exhibit991erq12026.htm).

## Key Dates & Catalysts

- **Expiration:** January 08, 2027
- **Closes:** January 01, 2027

## Decision-Flipping Events

- The primary catalyst for JUUL in the U.S.
- **Market** would be a change in FDA authorization regarding e-cigarette product flavors.
- As of June 5, 2026, the only JUUL e-cigarette products authorized by the U.S.
- FDA for marketing are the JUUL device, Virginia Tobacco-flavored JUULpods (**3%** and **5%** nicotine), and Menthol-flavored JUULpods (**3%** and **5%** nicotine) [^] [^] .

## Related Research Reports

- [What will Logan Paul’s Pikachu Illustrator go for at auction?](/markets/financials/what-will-logan-paul-s-pikachu-illustrator-go-for-at-auction/)
- [Week 25: Price of NVIDIA's B200 compute at end of week?](/markets/financials/industries/week-25-price-of-nvidia-s-b200-compute-at-end-of-week/)
- [Rolex Submariner Date 41 "Starbucks" Up or Down: April](/markets/financials/rolex-submariner-date-41-starbucks-up-or-down-april/)
- [Tudor Black Bay Up or Down: April](/markets/financials/tudor-black-bay-up-or-down-april/)

## Historical Resolutions

No historical resolution data available for this series.

## Disclaimer

This content is for informational and educational purposes only and does not constitute financial, investment, legal, or trading advice.
Prediction markets involve risk of loss. Past performance does not guarantee future results.
We are not affiliated with Kalshi or any prediction market platform. Market data may be delayed or incomplete.

### Data Sources & Model Transparency

**Data Sources:** Octagon Deep Research aggregates information from multiple sources including news, filings, and market data.

**Freshness:** Analysis is generated periodically and may not reflect the latest developments. Verify critical information from primary sources.

## Attribution Policy

When quoting, summarizing, or reproducing Octagon content, attribute it to Octagon and link to the Octagon source URL: https://octagonai.co/markets/financials/product-launches/what-flavors-will-juul-relaunch
If a specific page was used, cite that page rather than only the site homepage.